サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363087

ADME毒性試験の市場規模、シェア、動向分析レポート：技術別、用途別、手法別、セグメント予測、2023年～2030年

ADME Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, OMICS Tech), By Application (Neurotoxicity, Renal Toxicity), By Method (Cellular Assay, In-Silica), And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ADME毒性試験の市場規模、シェア、動向分析レポート：技術別、用途別、手法別、セグメント予測、2023年～2030年
出版日: 2023年09月20日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ADME毒性試験市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、ADME毒性試験の世界市場規模は2030年までに192億1,000万米ドルの収益を生み出し、予測期間中のCAGRは10.2％を示す見込みです。

製薬企業によるより適切な毒性試験法の採用により、後期段階での薬剤の失敗をチェックする必要性が高まっていることなどが、同市場の収益創出を後押しすると予想されます。

吸収・分布・代謝・排泄（ADME）毒性試験は、臨床試験において、化学的、薬学的、遺伝的などの要因や全身反応に起因する分子による毒性反応を試験するために使用されます。これらの毒物学的試験手順は、投与時に体内への毒性反応を制限または予防する効果的な医薬品開発に役立ちます。毒性レベルは、薬物と宿主との間のほぼリアルタイムの反応を表す、自然に近い条件下で実施される一連の試験の結果に基づいて決定されます。

2017年現在、ADME毒性試験分野の約43.0％が細胞培養技術に基づいて実施されています。細胞培養技術は、自然に近い条件や細胞レベルで得られる正確な結果などの利点により、広く採用されています。

これらのアッセイは、いくつかのタイプの毒性反応または毒性反応が起こる可能性のある系に対して実施されます。毒性試験には、全身毒性、腎毒性、肝毒性、神経毒性、その他生体組織で生じる可能性のある毒性などがあります。試験方法の動向は現在進行中であり、この動向は薬剤分子を開発する多くの企業が取り上げることになると思われます。これは創薬プロセスを加速し、市場の成長を後押しすると思われます。

ADME毒性試験市場のレポートハイライト

  • 後期段階での医薬品失敗の割合が増加し、医薬品開発のための貴重な時間と投資が失われることが市場を牽引しています。また、OMICS技術の成長と採用の増加が、今後数年間の収益創出を押し上げると予想されます。
  • 北米は、多数の製薬会社が新規分子の商業的上市を目指して競争しているため、ADME毒性試験の最大市場となっています。
  • アジア太平洋とラテンアメリカの新興国市場は、多くの多国籍企業や地元企業が市場への参入を目指しているため、大きく成長する見込みです。また、イノベーションと成長機会のある市場での地位向上を目指しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ADME毒性試験市場の変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • ADME毒性試験市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 ADME毒性試験：技術別推定・動向分析

  • ADME毒性試験市場：重要なポイント
  • ADME毒性試験市場：動向と市場シェア分析、2022年および2030年
  • 細胞培養
  • 高スループット
  • 分子イメージング
  • オミックステクノロジー

第5章 ADME毒性試験市場：用途別推定・動向分析

  • ADME毒性試験市場：重要なポイント
  • ADME毒性試験市場：動向と市場シェア分析、2022年および2030年
  • 全身毒性
  • 腎毒性
  • 肝毒性
  • 神経毒性
  • その他の毒性

第6章 ADME毒性試験市場：手法別推定・動向分析

  • ADME毒性試験市場：重要なポイント
  • ADME毒性試験市場：動向と市場シェア分析、2022年および2030年
  • 細胞アッセイ
  • 生化学的アッセイ
  • インシリカ
  • 生体外

第7章 ADME毒性試験市場：地域別推定・動向分析

  • 地域別の展望
  • 地域別のADME毒性試験市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Thermo Fisher Scientific Inc.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • Curia Global, Inc.
    • Dassault Systemes
    • Beckman Coulter, Inc., (Danaher)
    • Catalent, Inc
    • Charles River Laboratories
    • Labcorp Drug Development
    • Eurofins Scientific
    • GE HealthCare
    • Miltenyi Biotec
    • IQVIA Inc
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 3 North America ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 5 North America ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 7 U.S. ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 9 Canada ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 10 Canada ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 12 Europe ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 13 Europe ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 15 Europe ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Germany ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 19 UK ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 20 UK ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 22 France ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 23 France ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 24 France ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 25 Italy ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Italy ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 28 Spain ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Spain ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 31 Sweden ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Sweden ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 34 Norway ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Norway ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 37 Denmark ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Denmark ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Japan ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 47 China ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 48 China ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 49 China ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 50 India ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 51 India ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 52 India ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 53 Australia ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Australia ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 56 Thailand ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Thailand ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 59 South Korea ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 60 South Korea ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 62 Latin America ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Latin America ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 65 Latin America ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Brazil ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 69 Mexico ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 70 Mexico ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 72 Argentina ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Argentina ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 80 South Africa ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 85 UAE ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 86 UAE ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 88 Kuwait ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 89 Kuwait ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait ADME toxicology testing market, by method, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 ADME toxicology testing: Market outlook
  • Fig. 9 ADME toxicology testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 ADME toxicology testing market driver impact
  • Fig. 15 ADME toxicology testing market restraint impact
  • Fig. 16 ADME toxicology testing market strategic initiatives analysis
  • Fig. 17 ADME toxicology testing market: Technology movement analysis
  • Fig. 18 ADME toxicology testing market: Technology outlook and key takeaways
  • Fig. 19 Cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 High throughput market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Molecular imaging market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 OMICS technology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 ADME toxicology testing market: Application movement analysis
  • Fig. 24 ADME toxicology testing market: Application outlook and key takeaways
  • Fig. 25 Systemic toxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Renal toxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Hepatotoxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Neurotoxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Other toxicities market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 ADME toxicology testing market: Method movement analysis
  • Fig. 31 ADME toxicology testing market: Method outlook and key takeaways
  • Fig. 32 Cellular assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Biochemical assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 In-silica market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Ex-vivo market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Global ADME toxicology testing market: Regional movement analysis
  • Fig. 37 Global ADME toxicology testing market: Regional outlook and key takeaways
  • Fig. 38 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-627-1

ADME Toxicology Testing Market Growth & Trend:

The global ADME toxicology testing market size is expected to generate a revenue of USD 19.21 billion by 2030, according to a new report by Grand View Research, Inc.., exhibiting a CAGR of 10.2% during the forecast period. Factors such as increased need to check late-stage drug failures with the adoption of more appropriate toxicity testing methods by pharmaceutical companies are expected to aid revenue generation for the market.

Absorption, distribution, metabolism, and excretion (ADME) toxicology testing is used to test toxic reactions caused by molecules in clinical trials on factors and systemic reactions such as chemical, pharmaceutical, and genetic. These toxicology testing procedures help in effective drug development, which limits or prevents toxic reactions to the body when administered. Toxicity levels are decided on the results of a series of tests conducted in near-natural conditions, which represent almost real-time reactions between the drug and the host.

As of 2017, approximately 43.0% of ADME toxicology testing areas carried out are based on cell culture tech. Cell culture technology is adopted widely owing to advantages such as near-natural conditions and accurate results obtained at a cellular level.

These assays are conducted for several types of toxic reactions or systems where toxic reactions might take place. Some of the toxicity tests are systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other toxicities that might result in living tissue. Advancements in testing methods are underway and this trend is likely to be picked up by many companies developing drug molecules. This will speed up the drug discovery process and boost the market growth.

ADME Toxicology Testing Market Report Highlights:

  • The market is driven by an increasing ratio of late-stage drug failures, resulting in loss of valuable time and investment for drug development. Growth and increasing adoption of OMICS technology is also expected to boost revenue generation in the coming years
  • North America is the largest market for ADME toxicology testing owing to the presence of a large number of pharmaceutical companies competing for the commercial launch of novel molecules
  • Developing regions of Asia Pacific and Latin America are set to grow considerably as many multinational and local players are striving to enter the market. They are also looking to improve their hold in markets that present innovation and growth opportunities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Application
    • 1.1.3. Method
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
    • 2.2.3. Method outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. ADME Toxicology Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. ADME Toxicology Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. ADME Toxicology Testing: Technology Estimates & Trend Analysis

  • 4.1. ADME Toxicology Testing Market: Key Takeaways
  • 4.2. ADME Toxicology Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Cell Culture
    • 4.3.1. Cell Culture market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. High Throughput
    • 4.4.1. High throughput market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Molecular Imaging
    • 4.5.1. Molecular imaging market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. OMICS Technology
    • 4.6.1. OMICS technology market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. ADME Toxicology Testing Market: Application Estimates & Trend Analysis

  • 5.1. ADME Toxicology Testing Market: Key Takeaways
  • 5.2. ADME Toxicology Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Systemic Toxicity
    • 5.3.1. Systemic toxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Renal Toxicity
    • 5.4.1. Renal toxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Hepatotoxicity
    • 5.5.1. Hepatotoxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Neurotoxicity
    • 5.6.1. Neurotoxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Other Toxicities
    • 5.7.1. Other toxicities market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. ADME Toxicology Testing Market: Method Estimates & Trend Analysis

  • 6.1. ADME Toxicology Testing Market: Key Takeaways
  • 6.2. ADME Toxicology Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Cellular Assay
    • 6.3.1. Cellular assay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Biochemical Assay
    • 6.4.1. Biochemical assay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. In-Silica
    • 6.5.1. In-silica market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Ex-vivo
    • 6.6.1. Ex-vivo market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. ADME Toxicology Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. ADME Toxicology Testing Market by Region: Key Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Thermo Fisher Scientific Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Promega Corporation
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Agilent Technologies, Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Curia Global, Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Dassault Systemes
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Beckman Coulter, Inc., (Danaher)
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Catalent, Inc
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Charles River Laboratories
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Labcorp Drug Development
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Eurofins Scientific
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. GE HealthCare
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Miltenyi Biotec
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. IQVIA Inc
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives